Chemistry:Iron(II,III) oxide

Iron(II,III) oxide

Names
IUPAC name iron(II) iron(III) oxide
Other names ferrous ferric oxide, ferrosoferric oxide, iron(II,III) oxide, magnetite, black iron oxide, lodestone, rust, iron(II) diiron(III) oxide
Identifiers
CAS Number	1317-61-9 Y
3D model (JSmol)	Interactive image
ChEBI	CHEBI:50821 Y
ChEMBL	ChEMBL1201867 N
ChemSpider	17215625 Y
PubChem CID	16211978
UNII	XM0M87F357 Y
InChI InChI=1S/3Fe.4O Y Key: SZVJSHCCFOBDDC-UHFFFAOYSA-N Y InChI=1/3Fe.4O/rFe3O4/c1-4-2-6-3(5-1)7-2 Key: SZVJSHCCFOBDDC-QXRQKJBKAR
SMILES O1[Fe]2O[Fe]O[Fe]1O2
Properties
Chemical formula	Fe3O4 FeO.Fe2O3
Molar mass	231.533 g/mol
Appearance	solid black powder
Density	5 g/cm3
Melting point	1,597 °C (2,907 °F; 1,870 K)
Boiling point	2,623 °C (4,753 °F; 2,896 K)
Refractive index (nD)	2.42
Hazards
NFPA 704 (fire diamond)	0 0 1 OX
Thermochemistry
Std enthalpy of formation (ΔfH⦵298)	-1120.89 kJ·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
N verify (what is YN ?)
Infobox references

Iron(II,III) oxide, or black iron oxide, is the chemical compound with formula Fe₃O₄. It occurs in nature as the mineral magnetite. It is one of a number of iron oxides, the others being iron(II) oxide (FeO), which is rare, and iron(III) oxide (Fe₂O₃) which also occurs naturally as the mineral hematite. It contains both Fe²⁺ and Fe³⁺ ions and is sometimes formulated as FeO ∙ Fe₂O₃. This iron oxide is encountered in the laboratory as a black powder. It exhibits permanent magnetism and is ferrimagnetic, but is sometimes incorrectly described as ferromagnetic. Its most extensive use is as a black pigment (see: Mars Black). For this purpose, it is synthesized rather than being extracted from the naturally occurring mineral as the particle size and shape can be varied by the method of production.

Preparation

Heated iron metal interacts with steam to form iron oxide and hydrogen gas.

[math]\ce{ 3Fe + 4H2O->Fe3O4 + 4H2 }[/math]

Under anaerobic conditions, ferrous hydroxide (Fe(OH)₂) can be oxidized by water to form magnetite and molecular hydrogen. This process is described by the Schikorr reaction:

[math]\ce{ \underset{ferrous\ hydroxide}{3Fe(OH)2} -> \underset{magnetite}{Fe3O4} + \underset{hydrogen}{H2} + \underset{water}{2H2O} }[/math]

This works because crystalline magnetite (Fe₃O₄) is thermodynamically more stable than amorphous ferrous hydroxide (Fe(OH)₂ ).

The Massart method of preparation of magnetite as a ferrofluid, is convenient in the laboratory: mix iron(II) chloride and iron(III) chloride in the presence of sodium hydroxide.

A more efficient method of preparing magnetite without troublesome residues of sodium, is to use ammonia to promote chemical co-precipitation from the iron chlorides: first mix solutions of 0.1 M FeCl₃·6H₂O and FeCl₂·4H₂O with vigorous stirring at about 2000 rpm. The molar ratio of the FeCl₃:FeCl₂ should be about 2:1. Heat the mix to 70 °C, then raise the speed of stirring to about 7500 rpm and quickly add a solution of NH₄OH (10 volume %). A dark precipitate of nanoparticles of magnetite forms immediately.

In both methods, the precipitation reaction relies on rapid transformation of acidic iron ions into the spinel iron oxide structure at pH 10 or higher.

Controlling the formation of magnetite nanoparticles presents challenges: the reactions and phase transformations necessary for the creation of the magnetite spinel structure are complex. The subject is of practical importance because magnetite particles are of interest in bioscience applications such as magnetic resonance imaging (MRI), in which iron oxide magnetite nanoparticles potentially present a non-toxic alternative to the gadolinium-based contrast agents currently in use. However, difficulties in controlling the formation of the particles, still frustrate the preparation of superparamagnetic magnetite particles, that is to say: magnetite nanoparticles with a coercivity of 0 A/m, meaning that they completely lose their permanent magnetisation in the absence of an external magnetic field. The smallest values currently reported for nanosized magnetite particles is Hc = 8.5 A m⁻¹, whereas the largest reported magnetization value is 87 Am² kg⁻¹ for synthetic magnetite.

Pigment quality Fe₃O₄, so called synthetic magnetite, can be prepared using processes that use industrial wastes, scrap iron or solutions containing iron salts (e.g. those produced as by-products in industrial processes such as the acid vat treatment (pickling) of steel):

• Oxidation of Fe metal in the Laux process where nitrobenzene is treated with iron metal using FeCl₂ as a catalyst to produce aniline:

C₆H₅NO₂ + 3 Fe + 2 H₂O → C₆H₅NH₂ + Fe₃O₄

• Oxidation of Fe^II compounds, e.g. the precipitation of iron(II) salts as hydroxides followed by oxidation by aeration where careful control of the pH determines the oxide produced.

Reduction of Fe₂O₃ with hydrogen:

3Fe₂O₃ + H₂ → 2Fe₃O₄ +H₂O

Reduction of Fe₂O₃ with CO:

3Fe₂O₃ + CO → 2Fe₃O₄ + CO₂

Production of nano-particles can be performed chemically by taking for example mixtures of Fe^II and Fe^III salts and mixing them with alkali to precipitate colloidal Fe₃O₄. The reaction conditions are critical to the process and determine the particle size.

Iron(II) carbonate can also be thermally decomposed into Iron(II,III):

3FeCO
3 → Fe
3O
4 + 2CO
2 + CO

Reactions

Reduction of magnetite ore by CO in a blast furnace is used to produce iron as part of steel production process:

[math]\ce{ {Fe3O4} + 4CO -> {3Fe} + 4CO2 }[/math]

Controlled oxidation of Fe₃O₄ is used to produce brown pigment quality γ-Fe₂O₃ (maghemite):

[math]\displaystyle{ \ce{\underbrace{2Fe3O4}_{magnetite} + {1/2O2} -\gt }\ {\color{Brown}\ce{\underbrace{3(\gamma-Fe2O3)}_{maghemite}}} }[/math]

More vigorous calcining (roasting in air) gives red pigment quality α-Fe₂O₃ (hematite):

[math]\displaystyle{ \ce{\underbrace{2Fe3O4}_{magnetite} + {1/2O2} -\gt }\ {\color{BrickRed}\ce{\underbrace{3(\alpha-Fe2O3)}_{hematite}}} }[/math]

Structure

Fe₃O₄ has a cubic inverse spinel group structure which consists of a cubic close packed array of oxide ions where all of the Fe²⁺ ions occupy half of the octahedral sites and the Fe³⁺ are split evenly across the remaining octahedral sites and the tetrahedral sites.

Both FeO and γ-Fe₂O₃ have a similar cubic close packed array of oxide ions and this accounts for the ready interchangeability between the three compounds on oxidation and reduction as these reactions entail a relatively small change to the overall structure. Fe₃O₄ samples can be non-stoichiometric.

The ferrimagnetism of Fe₃O₄ arises because the electron spins of the Fe^II and Fe^III ions in the octahedral sites are coupled and the spins of the Fe^III ions in the tetrahedral sites are coupled but anti-parallel to the former. The net effect is that the magnetic contributions of both sets are not balanced and there is a permanent magnetism.

In the molten state, experimentally constrained models show that the iron ions are coordinated to 5 oxygen ions on average. There is a distribution of coordination sites in the liquid state, with the majority of both Fe^II and Fe^III being 5-coordinated to oxygen and minority populations of both 4- and 6-fold coordinated iron.

Properties

Sample of magnetite, naturally occurring Fe₃O₄.

Fe₃O₄ is ferrimagnetic with a Curie temperature of 858 K (585 °C). There is a phase transition at 120 K (−153 °C), called Verwey transition where there is a discontinuity in the structure, conductivity and magnetic properties. This effect has been extensively investigated and whilst various explanations have been proposed, it does not appear to be fully understood.

While it has much higher electrical resistivity than iron metal (96.1 nΩ m), Fe₃O₄'s electrical resistivity (0.3 mΩ m ) is significantly lower than that of Fe₂O₃ (approx kΩ m). This is ascribed to electron exchange between the Fe^II and Fe^III centres in Fe₃O₄.

Uses

Ferumoxytol

Clinical data
Trade names	Feraheme, Rienso
AHFS/Drugs.com	Monograph
MedlinePlus	a614023
License data	EU EMA: by INN US DailyMed: Ferumoxytol
Pregnancy category	US: N (Not classified yet)
Routes of administration	Intravenous infusion
ATC code	None
Legal status
Legal status	US: ℞-only EU: Rx-only
Identifiers
IUPAC name iron(2+);iron(3+);oxygen(2-)
CAS Number	1309-38-2 Y
DrugBank	DB06215
UNII	CLH5FT6412
KEGG	D04177
ChEBI	CHEBI:46726
Chemical and physical data
Formula	Fe3O4
Molar mass	231.531 g·mol−1
3D model (JSmol)	Interactive image
SMILES [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3]
InChI InChI=1S/3Fe.4O/q+2;2*+3;4*-2 Key:WTFXARWRTYJXII-UHFFFAOYSA-N

Fe₃O₄ is used as a black pigment and is known as C.I pigment black 11 (C.I. No.77499) or Mars Black.

Fe₃O₄ is used as a catalyst in the Haber process and in the water-gas shift reaction. The latter uses an HTS (high temperature shift catalyst) of iron oxide stabilised by chromium oxide. This iron–chrome catalyst is reduced at reactor start up to generate Fe₃O₄ from α-Fe₂O₃ and Cr₂O₃ to CrO₃.

Bluing is a passivation process that produces a layer of Fe₃O₄ on the surface of steel to protect it from rust. Along with sulfur and aluminium, it is an ingredient in steel-cutting thermite.

Medical uses

Nano particles of Fe₃O₄ are used as contrast agents in MRI scanning.

Ferumoxytol, sold under the brand names Feraheme and Rienso, is an intravenous Fe₃O₄ preparation for treatment of anemia resulting from chronic kidney disease. Ferumoxytol is manufactured and globally distributed by AMAG Pharmaceuticals.

Biological occurrence

Magnetite has been found as nano-crystals in magnetotactic bacteria (42–45 nm) and in the beak tissue of homing pigeons.

External links

• "Ferumoxytol". Drug Information Portal. U.S. National Library of Medicine. https://druginfo.nlm.nih.gov/drugportal/rn/1309-38-2.